Role at Aspiriant#
- Title on Schedule A
- Independent Board of Director
- Control
- Schedule A reports Jeanette Gorgas as a control person.
- Ownership
- Schedule A reports an under-5% ownership band.
- Tenure
- Schedule A reports this title since May 2025.
The firm
Aspiriant, LLC$18.05B regulatory AUM · 105 advisory staff · 74 officesFirm profileTitle and ownership as reported on Schedules A and B of the firm's Form ADV. Ownership percentages are the SEC's reporting bands, not exact figures. View Schedule A in the filing
Career on record#
The firm’s Form ADV Schedule A identifies this person as an officer. The SEC IAPD public individual lookup for CRD 2822174 did not return an individual record when checked on 17 September 2026; this profile therefore does not report individual registration, examination, employment, office, or disclosure information.
The officer listing does not establish an individual registration history. View the IAPD record
Registrations and exams#
An officer title or CRD number on Form ADV does not establish current investment adviser representative registration. No registration or examination counts are inferred from limited or unavailable individual adviser information.
Individual adviser registrations and examinations are not presented in this officer profile. View the IAPD record
Regulatory record#
This directory does not report disciplinary history, for any firm or individual, in either direction. The SEC publishes the complete record, including any disciplinary events, and it is the authoritative place to check one.
Where to check this individual's complete record, including any disciplinary history. View the IAPD record
Background#
The firm’s Schedule A lists Jeanette Gorgas as Independent Board of Director. Form ADV Part 1A, Schedule A
Background statements are attributed to the named source. Firm biographies are not regulatory records.
Common questions#
What is Jeanette Gorgas’s filed role?
The firm’s Form ADV Schedule A lists Jeanette Gorgas as Independent Board of Director, with the title acquired in May 2025.
Source: Form ADV Part 1A, Schedule A
Answered from the records above.
Leadership at Aspiriant#
Robert Joseph FrancaisChief Executive Officer, Board of DirectorsCRD 4604851
John David AllenChief Investment OfficerCRD 4051640
Summer Ann HammonsChief People OfficerCRD 6949757
Sandra Leigh BragarChief Client OfficerCRD 4533687
Ryan Paul BensonBoard of DirectorsCRD 6718865
Lynne BornChief Practice OfficerCRD 7236641
Shanda Susan GentryChief Compliance OfficerCRD 2183318- Michael Christopher LavalleGeneral CounselCRD 7713697
Marc CastellaniBoard of Directors - ChairCRD 2937879- Alec ManoukianChief Technology OfficerCRD 7893759
Young S KimChief Client Service Operations OfficerCRD 5306274
Helen Ann DietzBoard of DirectorsCRD 1268071- Andrew PuttermanIndependent Board of DirectorCRD 3122891
Gavin Paul NeilBoard of DirectorsCRD 6163690
The other officers and owners named on the firm's Schedule A.